Search
Search Constraints
You searched for: Author/Creator Spangenthal, SelwynLimit your search
- Spangenthal, Selwyn [remove] 7
- Respiratory organs -- Diseases -- Periodicals 6
- 616.2005 5
- 616.2 1
- 616.905 1
- AE adverse event -- ANOVA analysis of variance -- AUC0–12 area under the curve from 0 to 12 h -- BMI body mass index -- CFC chlorofluorocarbon -- CI confidence interval -- Cmax maximum observed plasma concentration -- Cmin lowest concentration in the dosing interval -- COPD chronic obstructive pulmonary disease -- CV coefficient of variation -- FDC fixed-dose combination -- FEV1 forced expiratory volume in 1 s -- FVC forced vital capacity -- GFF glycopyrronium/formoterol fumarate dihydrate -- GI gastrointestinal -- HFA hydrofluoroalkanes -- ICS inhaled corticosteroid -- ITT intent-to-treat -- IWRS Interactive Web-based Response System -- LABA long-acting β2-agonist -- LAMA long-acting muscarinic antagonist -- LLQ lower limit of quantification -- LSM least squares mean -- MDI metered dose inhaler -- mITT modified intent-to-treat -- NA not available -- PEFR peak expiratory flow rate -- PK pharmacokinetics -- R randomization -- SD standard deviation -- SE standard error -- TEAE treatment-emergent adverse event -- tmax time to reach maximum observed plasma concentration -- VHC valved holding chamber 1
- Appareil respiratoire -- Maladies -- Périodiques 1
- Appareil respiratoire -- Maladies -- Traitement -- Périodiques 1
- Bronchodilators -- COPD maintenance -- Co-Suspension™ Delivery Technology -- LAMA -- Metered dose inhaler 1
- Chest -- Diseases -- Great Britain -- Periodicals 1
- Chest -- Diseases -- Periodicals 1